Current therapeutic options in children with hypertrophic cardiomyopathy – own experience

Journal Title: Postępy Nauk Medycznych - Year 2014, Vol 27, Issue 9

Abstract

Introduction. The clinical course of hypertrophic cardiomyopathy (HCM) in children is very heterogeneous. In some children, the thickened heart muscle causes progressive heart failure and life-threatening arrhythmias. HCM is the most common cause of sudden cardiac death.Aim. The aim of study was retrospective analysis of clinical profile, current therapeutic options and sudden cardiac death risk assessment in children with HCM.Material and methods. We analyzed 108 children, mean age 9.7 ± 5.46 yrs with HCM diagnosed in the years 1991-2013. Mean follow-up was 6.4 ± 4.83 yrs. Patients demographics, clinical symptoms, treatment strategy as well as the results of echocardiography, ECG, 24 h Holter ECG, exercise test were analyzed.Results. Of the 108 patients studied 77 (71%) were treated only pharmacologically, in 4 (3.7) children RF catheter ablation was done, in 8 (7.4%) patients septal myectomy was performed. In 17 (15.7%) children with risk factors for sudden cardiac death ICD for primary (12/17) and secondary prevention (5/17) was implanted. The heart transplant was qualified in 6 (5.5%) patients who had symptoms of progressive heart failure. Among 108 patients 11 (10.6%) children died. The mean annual mortality rate was 1.34.Conclusions. In most children with HCM lifestyle modification and appropriate pharmacological therapy are sufficient, additional medical interventions are not necessary. In patients with symptomatic left ventricular outflow tract obstruction refractory to medical therapy a surgical myectomy should be considered. High-risk patients ought to be prospectively identified and ICD implantation should be considered, however further research is required to establish better criteria for primary prevention in children.

Authors and Affiliations

Lidia Ziółkowska, Monika Kowalczyk, Katarzyna Bieganowska, Wanda Kawalec

Keywords

Related Articles

Carbon monoxide intoxication

Carbon monoxide (CO) is one of the most common causes of inhalation poisoning worldwide. CO is an odorless, colorless gas that usually remains undetectable until exposure results in injury or death. Severe CO poisoning c...

Different pathophysiological conditions, clinical picture and therapeutic methods of juvenile systemic lupus erythematosus

Systemic lupus erythematosus is a multisystem inflammatory disease of autoimmune aetiology, the development of which involves genetic, hormonal and environmental factors. Approximately 20% of lupus cases have their onset...

Wczesna intensywna terapia behawioralna u dzieci z autyzmem – teoria i badania

Autyzm jest jednym z najpoważniejszych zaburzeń rozwoju. Mimo iż schorzenie to jest cały czas określane jako „enigma” ze względu na brak jednoznacznych odpowiedzi na wiele pytań z nim związany...

Obesity influence on health

Obesity is an important cause of increased morbidity and mortality in developed countries. In population follow up studies the lowest mortality was observed between BMI 21-25 kg/m2. Above this value mortality was higher...

Familial adenomatous polyposis of the colon

Familial adenomatous polyposis (FAP) is a well-known predisposition to the occurrence of a large number of polyps in the colon and rectum inherited in an autosomal dominant manner. The first symptoms of FAP are diarrhea...

Download PDF file
  • EP ID EP54942
  • DOI -
  • Views 160
  • Downloads 0

How To Cite

Lidia Ziółkowska, Monika Kowalczyk, Katarzyna Bieganowska, Wanda Kawalec (2014). Current therapeutic options in children with hypertrophic cardiomyopathy – own experience. Postępy Nauk Medycznych, 27(9), -. https://europub.co.uk/articles/-A-54942